Biotech Values

[marthambles]

RockRat

I think you can throw out the game theory, because Teva's overriding interest is in protecting its Copaxone franchise. The Lovenox profits will be meaningless to Teva. Squashing MNTA would, however, be extremely satisfying. Sure, Sandoz can match extremely low pricing, but what does that do to MNTA's cash flow?